age, according to the report in the International Journal of Cancer. </p>
<p>The study included 241 women with a BRCA1 or BRCA2 mutation who underwent screening at least one time between 1995 and 2006.</p>
<p>The screenings, which started at age 35 years or 5 years earlier than the youngest age at diagnosis of ovarian cancer in the family, involved annual pelvic examination, transvaginal ultrasound, and measurements of serum CA125, a blood test for ovarian cancer.</p>
<p>During a total of 470 screening visi